Cargando…
重组人血小板生成素对重型再生障碍性贫血患者异基因造血干细胞移植后血小板恢复的影响
OBJECTIVE: To investigate and analyze the impact on PLT recovery of recombinant human thrombopoietin (rhTPO) in severe aplastic anemia (SAA) patients with allogeneic hematopoietic stem cell transplantation (allo-HSCT). METHODS: A retrospective analysis of Hematology Division of General Hospital of J...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342989/ https://www.ncbi.nlm.nih.gov/pubmed/29562465 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.03.007 |
Ejemplares similares
-
重组人血小板生成素对非重型再生障碍性贫血免疫抑制治疗疗效的影响
Publicado: (2020) -
重组人血小板生成素对重型再生障碍性贫血免疫抑制治疗近期疗效的影响
Publicado: (2015) -
血小板生成素受体激动剂改善重型再生障碍性贫血疗效的研究进展
Publicado: (2017) -
艾曲泊帕、重组人血小板生成素联合标准免疫抑制治疗重型再生障碍性贫血16例疗效及安全性分析
Publicado: (2021) -
重组人血小板生成素治疗92例成人重型原发免疫性血小板减少症的临床观察
Publicado: (2015)